65 related articles for article (PubMed ID: 9657429)
1. Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension.
Boffa MC; Valsecchi L; Fausto A; Gozin D; Vigano' D'Angelo S; Safa O; Castiglioni MT; Amiral J; D'Angelo A
Thromb Haemost; 1998 Jun; 79(6):1092-5. PubMed ID: 9657429
[TBL] [Abstract][Full Text] [Related]
2. Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension.
Hsu CD; Copel JA; Hong SF; Chan DW
Obstet Gynecol; 1995 Dec; 86(6):897-9. PubMed ID: 7501335
[TBL] [Abstract][Full Text] [Related]
3. Adhesion molecules, activin and inhibin--candidates for the biochemical prediction of hypertensive diseases in pregnancy?
Hanisch CG; Pfeiffer KA; Schlebusch H; Schmolling J
Arch Gynecol Obstet; 2004 Sep; 270(2):110-5. PubMed ID: 12898146
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress in midpregnancy as a predictor of gestational hypertension and pre-eclampsia.
Rogers MS; Wang CC; Tam WH; Li CY; Chu KO; Chu CY
BJOG; 2006 Sep; 113(9):1053-9. PubMed ID: 16956336
[TBL] [Abstract][Full Text] [Related]
5. Maternal erythrocyte malondialdehyde level in preeclampsia prediction: a longitudinal study.
Basbug M; Demir I; Serin IS; Ozcelik B; Saraymen R; Narin F; Tayyar M
J Perinat Med; 2003; 31(6):469-74. PubMed ID: 14711102
[TBL] [Abstract][Full Text] [Related]
6. Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age.
De Paco C; Kametas N; Rencoret G; Strobl I; Nicolaides KH
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):292-300. PubMed ID: 18238965
[TBL] [Abstract][Full Text] [Related]
7. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia.
Chavarría ME; Lara-González L; García-Paleta Y; Vital-Reyes VS; Reyes A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):157-64. PubMed ID: 17706337
[TBL] [Abstract][Full Text] [Related]
8. Urinary calcium as an early marker for preeclampsia.
Sanchez-Ramos L; Jones DC; Cullen MT
Obstet Gynecol; 1991 May; 77(5):685-8. PubMed ID: 2014080
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of soluble vascular endothelial growth factor receptor 1 for preeclampsia in second-trimester].
Chen Q; Zhao Y; Zou L; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):161-4. PubMed ID: 17537299
[TBL] [Abstract][Full Text] [Related]
10. First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
Poon LC; Nekrasova E; Anastassopoulos P; Livanos P; Nicolaides KH
Prenat Diagn; 2009 Jun; 29(6):553-9. PubMed ID: 19242924
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
Shaarawy M; El Meleigy M; Rasheed K
J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
[TBL] [Abstract][Full Text] [Related]
12. Homeostatic model assessment and risk for hypertension during pregnancy: a longitudinal prospective study.
Romero-Gutiérrez G; Malacara JM; Amador N; Fierro-Martínez C; Muñoz-Guevara LM; Molina-Rodríguez R
Am J Perinatol; 2004 Nov; 21(8):455-62. PubMed ID: 15580541
[TBL] [Abstract][Full Text] [Related]
13. Endothelin system in normal and hypertensive pregnancy.
Slowinski T; Neumayer HH; Stolze T; Gossing G; Halle H; Hocher B
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():446S-449S. PubMed ID: 12193142
[TBL] [Abstract][Full Text] [Related]
14. Plasma level of soluble c-Met is tightly associated with the clinical risk of preeclampsia.
Zeng X; Sun Y; Yang HX; Li D; Li YX; Liao QP; Wang YL
Am J Obstet Gynecol; 2009 Dec; 201(6):618.e1-7. PubMed ID: 19766985
[TBL] [Abstract][Full Text] [Related]
15. Correlation between maternal plasma thrombomodulin and infant birth weight in hypertensive disorders of pregnancy.
Varol FG; Ozgen L; Sayin NC; Demir M
Clin Appl Thromb Hemost; 2009; 15(2):166-70. PubMed ID: 19022800
[TBL] [Abstract][Full Text] [Related]
16. Changes of plasma fibronectin levels in pregnancy induced hypertension.
Paneva-Masin J; Zafirovska K; Bogdanovska S; Lozance L; Gerasimovska B
Acta Med Croatica; 2000; 54(4-5):157-60. PubMed ID: 11379479
[TBL] [Abstract][Full Text] [Related]
17. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.
Enquobahrie DA; Williams MA; Butler CL; Frederick IO; Miller RS; Luthy DA
Am J Hypertens; 2004 Jul; 17(7):574-81. PubMed ID: 15233976
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of estrogens in patients with preeclampsia.
Zeisler H; Jirecek S; Hohlagschwandtner M; Knöfler M; Tempfer C; Livingston JC
Wien Klin Wochenschr; 2002 Jun; 114(12):458-61. PubMed ID: 12422581
[TBL] [Abstract][Full Text] [Related]
19. Recurrent preeclampsia and perinatal outcome: a study of women with recurrent preeclampsia compared with women with preeclampsia who remained normotensive during their prior pregnancies.
Mendilcioglu I; Trak B; Uner M; Umit S; Kucukosmanoglu M
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1044-8. PubMed ID: 15488119
[TBL] [Abstract][Full Text] [Related]
20. Low levels of maternal serum PAPP-A in early pregnancy and the risk of adverse outcomes.
Spencer CA; Allen VM; Flowerdew G; Dooley K; Dodds L
Prenat Diagn; 2008 Nov; 28(11):1029-36. PubMed ID: 18925584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
